Background: Beta-Thalassaemia Trait (β-TT) 
Introduction:
The thalassemia syndrome are heterogenous group of genetic blood disorders of haemoglobin synthesis, all of which result from reduced rate of production of one or more of globin chain of haemoglobin. Several types of 1. Junior Consultant Cardiology, Lab Aid Cardiac Hospital, Dhaka.
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Bangladesh lies in thalassaemia belt but it has no definitive data regarding carrier stat of haemoglobin disorder. A conservative World Health report estimates that 3% of our total populations are of β-thalassaemia carrier. 1 Beta thalassemia Trait (β-TT) is a carrier state in which only one allele is muted. Individual will suffer from microcytic hypochromic anaemia. Detection usually involves low MCV (<80 fL), Low MCH (<27 pg) and increase fraction of Haemoglobin A2 (>3.5%). 2 It is believed that β-TT confers advantage in iron positive balance. But in the recent years observers pointed out that β -TT can be associated with iron deficiency by some explanatory conditions. Because the sign of iron deficiency resembles as that of any anaemia and the blood picture as In a recent (2011) study by Kumar et al. found that 55.3% students were anaemic, of whom 36.7% were male and 63.3% were female among the University students (17-25) in Noakhali region of Bangladesh. 6 Iron deficiency is responsible for approximately 50% of all anaemia. 6 It is categorized as one of the 10 most serious health problem by World Health Organization (WHO). 5, 6 Iron deficiency associated with β-TT subjects require careful attention. If such subjects are properly identified and treated with iron, their anemia will improve; hence improve general wellbeing.
Methods:
This cross sectional study was carried out in Hematology OPD, BSMMU, Dhaka from January, 2014 to August, 2015. β-TT individual those who used to come for follow up or referral from other physician/institute or newly diagnosed were identified. Proper counseling was done them to include this study. Participants those were on iron therapy or H/O receiving iron therapy within last one month and history suggestive of concurrent any inflammatory or malignant disease which may affect serum ferritin were excluded.
Assurance and explanation was made them regarding merits and demerits of this study. If they were agreed and gave informed consent then relevant physical examination was done and 5 cc blood was collected for CBC and Iron profile. In addition 6 (11%) participants had serum ferritin 15-30 (µgm/L). These participants might have latent iron deficiency. On the other hand 9 (16.7%) had higher than normal serum ferritin level (>300 µgm/L). Those β-TT participants (16) had low serum ferritin (<15 µgm/L), among them 10 (62.5%) had low serum iron (<40 μg/dl), 9 (56.25%) had high TIBC (>407 μg/dl) and 12 (75%) had low T.Sat (<16%). β-TT with IDA had much lower statistically significant serum iron, ferritin, transferrin saturation and higher TIBC than that of β-TT with non-IDA. (Table III) Discussion:
In this small study we found about 30% participants had concomitant iron deficiency among 54 confirm β-TT participants. In addition we also found 11% participants had latent iron deficiency (serum ferritin 15-30µgm/L).
In 1987 Economidou et al. found in their study that iron deficiency was a common finding in female of reproductive age not receiving iron supplementation. 7 Iron status in β-TT has been area of interest for many authors due to the frequent iron over load in thalassaemia major. 8 Relative high frequency of iron deficiency in our β-TT participants (30%) has been corroborated with the results of other investigators. In the year 2007 Mujahida, et al. in their study documented that 30.2% of thalassaemia traits had IDA. 9 Similar results were also documented in subsequent studies, in the year 2012 by Dolai TK et al. 2 and in the year 2014 by Das R et al. 10 , reported prevalence of IDA in β-TT subjects were 19.3% and 20.7% respectively.
As the sample participants were mostly (78%) female of reproductive age (15-44 years), iron deficiency is also common in this age group. This view is in conformity with the results of other studies published in recent past. 2 The findings in this study also suggest that iron deficiency is a fairly common co-existing condition in β -TT.
In respect of Bangladesh co-existence might be due to poverty, gastrointestinal blood loss, helminthes infestation, low bioavailability and low iron content in food. Of course excessive menstruation, pregnancy and breast feeding also play a major role in IDA of female reproductive age.
Previously literatures suggested a protective effect on IDA in person with β-TT and cautioned against iron overloaded due to unnecessary supplementation. 10, 11 However recently published Indian data documented high incidence of IDA ranging from Moreover common practice is that, thalasaemic patient should not take iron or iron containing foods or drugs, which deprived them iron supplementation, those who are especially iron deficient. On the other hand patients with β-TT should be warned that their blood picture resembles iron deficiency and can be misdiagnosed. They should eschew empirical use of iron, yet iron deficiency can develop.
In this study we also found about 17% participants had higher than normal serum ferritin (>300 μgm/L). These participants might have iron overload. These iron overload might be due to low grade heamolysis or injudicious iron therapy or heamochromatosis . In 1985 Fargion S et al. found in their study, 50% of β-TT with iron overload had idiopathic heamochromatosis. 13 Lastly, the authors suggest that β-TT individuals those who are anaemic with low MCV and MCH might have co-existing iron deficiency, so iron profile should be checked routinely and if iron deficiency co-exists should be treated accordingly.
